drugset / Trial / NCT02676830

Evaluation of Absorption, Metabolism, and Excretion and Estimation of the Absolute Bioavailability of K-312

NCT02676830 ↗

Phase 1 Completed 13 enrolled Kowa Research Institute, Inc.
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to Evaluation of absorption, metabolism, and excretion of \[14C\]-K-312 and estimation of the absolute bioavailability of K-312 in healthy male subjects

Timeline

Start
2014-08
Primary completion
2015-02
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject K-312 Unknown 100 ug Oral
Subject K-312 Unknown 100 mg Oral

Indications